{"schema_version":"secwatch.filing_event.v1","accession":"0001459839-24-000003","form_type":"8-K","ticker":"SIBN","cik":"0001459839","company_name":"SI-BONE, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.239164+00:00","generated_at":"2026-06-07T02:11:38.879136+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"SI-BONE reports preliminary Q4 2023 revenue of $38.5-$38.7M, up ~21% YoY; FY2023 revenue ~$138.5-138.7M (+30%)","bullets":["Q4 worldwide revenue $38.5-$38.7M, up ~21% YoY; US revenue $36.5-$36.6M (+22%).","FY 2023 worldwide revenue $138.5-$138.7M, up ~30% YoY; US revenue $130.5-$130.6M (+32%).","Active US surgeons ~1,130 at quarter end, up ~22% YoY.","Cash and marketable securities ~$166M as of Dec 31, 2023; net cash usage $0.8M in Q4.","Preliminary results; full Q4 earnings call expected in Feb 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001459839-24-000003","json":"https://secwatch.observer/filing/0001459839-24-000003.json","markdown":"https://secwatch.observer/filing/0001459839-24-000003.md","text":"https://secwatch.observer/filing/0001459839-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1459839/000145983924000003/0001459839-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1459839/000145983924000003/sibn-20240108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:11:38.879136+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9dd3a2b8361f22d6b78750f5bbf5e3f4a208396f","claim":"SI-BONE, Inc. reported the fiscal year ended December 31, 2023 results: revenue $138.5-138.7 million.","evidence_excerpt":"Worldwide revenue expected to be in the range of $138.5-138.7 million, representing growth of approximately 30% compared to the prior year period","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1459839/000145983924000003/0001459839-24-000003-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$138.5-138.7 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"bc98d1292821067e8e18ea8d8b1b4fdc394fdec2","claim":"SI-BONE, Inc. reported the fourth quarter ended December 31, 2023 results: revenue $38.5-$38.7 million.","evidence_excerpt":"Worldwide revenue expected to be in the range of $38.5-$38.7 million, representing growth of approximately 21% compared to the prior year period","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1459839/000145983924000003/0001459839-24-000003-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$38.5-$38.7 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}